Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results

YANGZHOU, China, April 24, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today reported its financial ...

2024-04-24 19:00 1

Esaote Group: Shareholders' Meeting approves financial statements as of 31 December 2023

* Consolidated revenues up to €273.2 million (+6.5%), EBITDA stands at €41.7 million (+24.5%); EBIT up to €13.4 million and net profit up to €6.2 million. * Sales increased in all business lines, especially in the ultrasound segment (+9.7%). Second consecutive record sales year for MRI (+3.3%...

2024-04-24 18:00 387

Esaote Group: Shareholders' Meeting approves financial statements as of 31 December 2023

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved inEurope Conditional marketing authorization is based on statistically significant and clinically meaningful results from the phase-III PROTECT trial ST. GALLEN, Switzerland and SAN DIEGO, April 24, 2024 /PR...

2024-04-24 15:00 639

Samsung Biologics Reports First Quarter 2024 Financial Results

* Recorded Q1'24 consolidated revenue of KRW 946.9 billion * Recorded Q1'24 consolidated operating profit of KRW 221.3 billion * Sustained growth driven by ongoing strategic expansion in capacity and portfolio INCHEON, South Korea, April 24, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 20794...

2024-04-24 14:45 579

RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE

- The choice is the individual's hand to treat oneself with love and care, where judgments and negative opinions have no place in personal beauty journeys. KUALA LUMPUR, Malaysia, April 24, 2024 /PRNewswire/ -- RELIFE, the dermatology and aesthetic medicine division of A. Menarini, a wholl...

2024-04-24 10:00 739

RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

Hanmi Pharmaceutical announces Clinical Trial Collaboration with MSD to evaluate 'BH3120' in combination with KEYTRUDA in phase 1 clinical trial in patients with progressive or metastatic solid tumors SEOUL, South Korea, April 23, 2024 /PRNewswire/ -- Hanmi Pharmaceutical (KOSPI: 128940, CEO:Jae...

2024-04-24 09:27 669

Significant Case Intake Efficiencies Found in Newly Launched Life Sciences Generative AI Solution

Advanced Intake™ demonstrates up to 65% efficiency gains in adverse case intake and 90% data extraction accuracy and quality BOSTON, April 23, 2024 /PRNewswire/ -- ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, today revealed details about itsAdvanced Inta...

2024-04-23 20:00 790

Zayed Sustainability Prize's Beyond2020 Initiative Deploys Life-saving Digital Mammograms in Costa Rica

AI-powered mammography services will help detect breast cancer cases among women living in underprivileged communities acrossCosta Rica ABU DHABI, UAE, April 23, 2024 /PRNewswire/ -- Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE's pioneering award for su...

2024-04-23 18:39 804

Zayed Sustainability Prize's Beyond2020 Initiative Deploys Life-saving Digital Mammograms in Costa Rica

OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market

SEOUL, South Korea, April 23, 2024 /PRNewswire/ -- OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding (MOU) with SillaJen, a Kosdaq-listed biotech firm with a pipeline of immuno-oncology drug candidates, to share technology and clinical ...

2024-04-23 18:37 1087

Smartee Showcases Mandibular Repositioning Technology at IDEM Singapore 2024

SINGAPORE, April 23, 2024 /PRNewswire/ -- Smartee Denti-Technology, a global leader in digital orthodontic solutions, proudly announces its successful participation in the International Dental Exhibition and Meeting (IDEM) 2024, held fromApril 19 to April 21 at Marina Bay Sands, Singapore. &...

2024-04-23 16:51 1003

Smartee Showcases Mandibular Repositioning Technology at IDEM Singapore 2024

Borsch Med Introduces Chondroitin Supplements to Singapore for Healthy Joints

Chondroitin-based supplements from Zeria Pharmaceutical launched to promote an active lifestyle SINGAPORE, April 23, 2024 /PRNewswire/ -- Borsch Med Pte Ltd (BM), a leading Traditional Chinese Medicine (TCM), Health and Nutrition company based in Singapore, operated and managed by professionals i...

2024-04-23 15:00 876

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)

SAN DIEGO and WUHAN, China, April 23, 2024 /PRNewswire/ -- HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the N...

2024-04-23 14:54 789

VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES

* Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes * TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing pancreatic islet cells BOSTON and BORDEAUX, France, April 23, 2024 /PRNewswire/ -- Vertex Pha...

2024-04-23 12:45 970

VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES

Virtus Fertility Centre Singapore sets up a ReadyBaby Fertility Grant for those facing financial and family planning challenges

This grant is designed to support eligible Singaporean couples in achieving their dream of having a baby, offering them a chance at pregnancy in a private setting. SINGAPORE, April 23, 2024 /PRNewswire/ -- To help married Singaporean couples facing infertility and aspiring to start a family, Vir...

2024-04-23 10:59 920

Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre-A+ Financing

SHANGHAI, April 22, 2024 /PRNewswire/ -- Brise Pharmaceuticals Co., LTD. (Brise), a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A and Pre-A+ financing with a total of approximately$20 million. This Pre-A round is led by Shunxi F...

2024-04-23 08:00 790

PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024

* Preclinical data from the next generation eyedrop platform to be unveiled for the first time at ARVO 2024 DAEJEON, South Korea, April 22, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therap...

2024-04-23 07:25 1215

TraceLink Named Finalist in the Prestigious Business Transformation & Operational Excellence Awards 2024

BOSTON, April 23, 2024 /PRNewswire/ -- TraceLink, a global leader in integrated digital supply network solutions, is proud to announce its recognition as a finalist in the esteemed Business Transformation & Operational Excellence Awards 2024. This recognition underscores TraceLink's commitment to...

2024-04-23 04:25 1000

Datasea Inc. (NASDAQ: DTSS) and iPower Inc. (NASDAQ: IPW) Collaborate to Expand Product Distribution in US Online Markets

BEIJING, April 22, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a trailblazing digital technology company incorporated in Nevada, dedicated to innovative solutions in acoustic high tech and 5G-Artificial Intelligence ("AI") multimodal communication technology inth...

2024-04-22 22:00 864

Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial

Trial results anticipated in early Q3 this year SYDNEY, April 22, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces the full enrolment of 167 participants in the Company's XanaCIDD phase 2a clinical trial in patients with cognitive impairment in major depressive disorder (MDD)....

2024-04-22 20:30 719

Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns

News Summary: * New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics. * Reduces problematic non-specific binding, minimizes mobile phase method development challenges, and provides h...

2024-04-22 20:00 884

12 3 4 5 ... 576